kevin niswender Archives
Vanderbilt’s neurovascular chip project moves into new phase
Nov. 18, 2014—Vanderbilt researchers will play a key role in the second phase of the federal "tissue chip for drug screening" program.
Vanderbilt study supports notion ‘You are what you eat’
Jun. 2, 2014—An international research group led by Vanderbilt University scientists has shown for the first time that a lipid, or fat molecule, can regulate “psychostimulant” behaviors by interacting with a brain protein.
Vanderbilt’s Hong, Niswender elected to ASCI
Apr. 18, 2013—Charles Hong, M.D., Ph.D., and Kevin Niswender, M.D., Ph.D., have been elected to membership in the American Society of Clinical Investigation (ASCI), one of the nation’s most respected medical honor societies.
Vanderbilt-led team to develop ‘microbrain’ to improve drug testing
Jul. 24, 2012—Creating a device out of human cells that simulates brain chemistry is the goal of a $6.4 million grant which is part of major new federal initiative to develop a series of “organs on a chip” designed to improve the drug development process.
